Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortNucleoside chemotherapy for pancreatic, lung, bladder and ovarian cancers.Platinum chemotherapy with less nerve and kidney toxicity than cisplatin.
Body systemCancerCancer
Drug classAntimetabolitesPlatinum chemotherapy
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesPancreatic cancer, Lung cancer, Ovarian cancer, Bladder and breast cancerOvarian cancer, Lung cancer, Head and neck cancer, Breast and other cancers
How it worksBlocks cancer cells from copying their DNA.Damages cancer cell DNA so the cells die.
Starts workingDepends on the cancer and regimenDepends on the cancer and regimen
Half-lifeMinutes (gemcitabine); 8–17 hours (metabolite)About 3–6 hours
Typical adult doseDosed by your cancer team according to the treatment protocol.Dosed by your cancer team according to the treatment protocol.
FormsIV infusionIV infusion
Common side effectsLow blood counts, Nausea, Rash, Flu-like symptoms, Swollen anklesNausea and vomiting, Tiredness, Low blood counts, Hair thinning
Serious side effectsSevere low blood counts, Lung inflammation, Haemolytic uraemic syndrome (rare), Capillary leak (rare)Severe low platelets or white cells, Allergic reactions after repeated cycles, Kidney effects
Don't take ifSevere kidney or liver impairment; Radiotherapy given at the same time; PregnancySevere bone marrow suppression; Allergy to platinum drugs; Pregnancy
AlcoholBest to limit. Alcohol can add to nausea and tiredness; ask your cancer team.Best to limit. Alcohol can add to nausea and tiredness; ask your cancer team.
PregnancyUsually avoidedCan harm a developing baby. Effective contraception is advised during and after treatment.Usually avoidedCan harm a developing baby. Effective contraception is advised during and after treatment.
BreastfeedingUsually avoidedAvoid breastfeeding during treatment.Usually avoidedAvoid breastfeeding during treatment.
In use since——
Brand namesUnited States: Gemzar, InfugemUnited Kingdom: GemzarIndia: Gemcite, GemzarUnited States: Paraplatin (generic available)United Kingdom: Carboplatin (generic)India: Kemocarb, Carboplatin (generic)
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H
ATC codeL01BC05L01XA02

Taken together

  • ModerateGemcitabine + Carboplatin: Added bone marrow suppression

    Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.

Open in the interaction checker